- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04754490
Exploring Breathing Patterns (EPISODE)
Exploring Patterns of Speech and Breathing to Indicate the Presence of Obstructive Disease
Study Title Exploring patterns of speech and breathing to indicate the presence of obstructive respiratory disease.
Study Design Prospective Case Control Study Study Participants Participants will be patients attending the respiratory physiology clinic at the Cardiopulmonary Unit, Prince Charles Hospital for an assessment of their lung function. In addition a cohort of control participants without obstructive respiratory disease will be recruited with the assistance of the British Lung Foundation charity.
Planned Size of Sample (if applicable) We have received funding for 52 ½ day sessions and we plan to recruit on average 2 participants per session. As such we aim to recruit a minimum of 100 participants. In addition we are working with the British Lung Foundation to recruit a smaller Cohort of control participants and aim to recruit a minimum of 25 control participants.
Planned Study Period Jan 2019 - Aug 2019 Research Aim(s) This primary objective of this novel study it to create an anonymised database of speech patterns of patients with chronic respiratory disease and healthy aged matched controls for comparison with lung function and medical history.
The primary aims are to:
- Collect breathing patterns from individuals under a range of talking modalities
- Understand how easy it is to gather short speech recordings
- Explore the preferences of patients to be recorded talking
Aperçu de l'étude
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Wales
-
Abercynon, Wales, Royaume-Uni, CF45 4SN
- Cwm Taf Morgannwg Health Board
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
Adult patient >18 years old referred for spirometry in the Respiratory Physiology Clinic at Prince Charles Hospital;
Eligibility Criteria - Control Participants Control participants will be contact through the British Lung Foundations local groups who have indicated their willingness to be involved in local clinical research to act as control participants. As all prospective participants will have had their respiratory function measured before taking part by a Respiratory Physiologist, we do not expect to have to screen for medical issues for participation in the study. Furthermore, the actual tests the participants will be undertaking will be non - invasive, submaximal and will require little or no effort.
La description
6.1.2 Inclusion criteria Patient Participants
- Adult patient >18 years old referred for spirometry in the Respiratory Physiology Clinic at Prince Charles Hospital;
- Clinically defined obstructive or restrictive respiratory disease (indicated by spirometry)
- Clinically stable (indicated by being able to undergo spirometry)
- No significant unstable disease co-morbidities (indicated by being able to undergo spirometry)
- Capable of providing informed consent.
- Willing to take part in all study measurements.
- The speaking exercise will be conducted in English on this study.
- Participants are not taking part in any other research. 6.1.3 Inclusion criteria Control Participants
1. No obstructive or restrictive respiratory disease (indicated by spirometry) 2. Clinically stable (indicated by being able to undergo spirometry) 3. No significant unstable disease co-morbidity's (indicated by being able to undergo spirometry) 4. Capable of providing informed consent. 5. Willing to take part in all study measurements. 6. The speaking exercise will be conducted in English on this study. 7. Participants are not taking part in any other research.
6.1.4 Exclusion criteria for both Patient and Control Participants
- Any form of challenge testing in the Respiratory Physiology Department involving salbutamol.
- Severe Sensory and/or Cognitive Impairment
- Inability to complete study measurements
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Collect breathing patterns from individuals under a range of talking modalities
Délai: less than 5 minutes
|
breathing pattern
|
less than 5 minutes
|
|
Understand how easy it is to gather short speech recordings
Délai: 3 minutes
|
verbal description
|
3 minutes
|
|
Explore the preferences of patients to be recorded talking
Délai: 3 minutes
|
verbal description
|
3 minutes
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 256266
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .